CST-2140 by CuraSen Therapeutics for Orthostatic Hypotension: Likelihood of Approval

CST-2140 is under clinical development by CuraSen Therapeutics and currently in Phase I for Orthostatic Hypotension.

Do podcasts influence health behaviors?

Researchers examine the impact of podcasts on health behaviors and outcomes, use patterns, and individual perceptions.

November 22, 2024

Medicare Pay, Prior Auth, and More: A Q&A With the AMA’s President-Elect

As the president-elect of the American Medical Association (AMA), Bobby Mukkamala (pronounced “moo-COM-ala”), MD, an otolaryngologist in Flint, Michigan, will be working on the association’s

June 21, 2024

Relay licenses cancer drug to Korean biotech for $75M

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.